Application

Trademark

LEO Pharma A/S

Trademark/Service Mark Application, Principal Register

PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 97139262
Filing Date: 11/23/2021

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 97139262
MARK INFORMATION
*MARK \\TICRS\EXPORT18\IMAGEOUT 18\971\392\97139262\xml1 \ APP0002.JPG
SPECIAL FORM YES
USPTO-GENERATED IMAGE NO
COLOR MARK NO
*DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of an "A" design with a darker arch and a lighter horizontal swoop curving up and to the right.
PIXEL COUNT ACCEPTABLE YES
PIXEL COUNT 284 x 299
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK LEO Pharma A/S
*MAILING ADDRESS Industriparken 55
*CITY Ballerup
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY Denmark
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
2750
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE public limited company (plc)
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY WHERE LEGALLY ORGANIZED Denmark
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceutical and medical preparations for treatment of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and for treatment of the skin.
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 038 
*IDENTIFICATION Providing online forums for information and communication about skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin.
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 042 
*IDENTIFICATION Scientific and medical research in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin; research and development services and scientific research and testing of pharmaceuticals, all in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin; providing information and consulting services in the field of scientific research and development services and scientific research in relation to skin diseases and treatment of the skin; testing of pharmaceuticals in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin.
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 044 
*IDENTIFICATION Medical testing for diagnostic or treatment purposes, in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin; medical services in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin; medical, health and pharmaceutical consultation services in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin.
FILING BASIS SECTION 1(b)
ATTORNEY INFORMATION
NAME B. Brett Heavner
ATTORNEY DOCKET NUMBER 14894.0074
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Finnegan, Henderson, Farabow, Garrett & Dunner LLP
STREET 901 New York Avenue NW
CITY Washington
STATE District of Columbia
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 20001
PHONE 202-408-4000
FAX 202-408-4400
EMAIL ADDRESS docketing@finnegan.com
OTHER APPOINTED ATTORNEY all the other attorneys of Finnegan, Henderson, Farabow, Garrett & Dunner LLP
CORRESPONDENCE INFORMATION
NAME B. Brett Heavner
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE docketing@finnegan.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) travis.smith@finnegan.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 4
APPLICATION FOR REGISTRATION PER CLASS 350
*TOTAL FEES DUE 1400
*TOTAL FEES PAID 1400
SIGNATURE INFORMATION
SIGNATURE /Tom Friis-Mikkelsen/
SIGNATORY'S NAME Tom Friis-Mikkelsen
SIGNATORY'S POSITION Senior Manager, Head of Trademarks, Designs and Domain Names
DATE SIGNED 11/23/2021
SIGNATURE METHOD Sent to third party for signature



PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Application, Principal Register

Serial Number: 97139262
Filing Date: 11/23/2021

To the Commissioner for Trademarks:

MARK: (Stylized and/or Design, see mark) The applicant is not claiming color as a feature of the mark. The mark consists of an "A" design with a darker arch and a lighter horizontal swoop curving up and to the right.
The applicant, LEO Pharma A/S, a public limited company (plc) legally organized under the laws of Denmark, having an address of
      Industriparken 55
      Ballerup 2750
      Denmark
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  Pharmaceutical and medical preparations for treatment of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and for treatment of the skin.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 038:  Providing online forums for information and communication about skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 042:  Scientific and medical research in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin; research and development services and scientific research and testing of pharmaceuticals, all in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin; providing information and consulting services in the field of scientific research and development services and scientific research in relation to skin diseases and treatment of the skin; testing of pharmaceuticals in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 044:  Medical testing for diagnostic or treatment purposes, in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin; medical services in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin; medical, health and pharmaceutical consultation services in the field of skin diseases, atopic dermatitis, autoimmune and inflammatory diseases and in relation to treatment of the skin.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.




The owner's/holder's proposed attorney information: B. Brett Heavner. Other appointed attorneys are all the other attorneys of Finnegan, Henderson, Farabow, Garrett & Dunner LLP. B. Brett Heavner of Finnegan, Henderson, Farabow, Garrett & Dunner LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      901 New York Avenue NW
      Washington, District of Columbia 20001
      United States
      202-408-4000(phone)
      202-408-4400(fax)
      docketing@finnegan.com
The docket/reference number is 14894.0074.
B. Brett Heavner submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant's current Correspondence Information:
      B. Brett Heavner
       PRIMARY EMAIL FOR CORRESPONDENCE: docketing@finnegan.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): travis.smith@finnegan.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $1400 has been submitted with the application, representing payment for 4 class(es).

Declaration

Declaration Signature

Signature: /Tom Friis-Mikkelsen/   Date: 11/23/2021
Signatory's Name: Tom Friis-Mikkelsen
Signatory's Position: Senior Manager, Head of Trademarks, Designs and Domain Names
Signatory's Phone Number: Not Provided
Signature method: Sent to third party for signature
Payment Sale Number: 97139262
Payment Accounting Date: 11/23/2021

Serial Number: 97139262
Internet Transmission Date: Tue Nov 23 12:10:03 ET 2021
TEAS Stamp: USPTO/BAS-XX.XXX.X.X-2021112312100349690
5-97139262-781bf3dd8864c8b75432d414617b8
279d621414e2e6a7a9b5a44b39f72e732f-CC-10
012841-20211118221137695408

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed